Sign in

Newtyn Management, LLC

CIK:0001569241
Hedge Fund
$2B AUM
34 holdings
New York, NY, US
Founded:2012
12 employees
Latest filing:Jun 30, 2025

Newtyn Management, LLC is an SEC-registered investment adviser headquartered in New York, New York. Founded in 2012, the firm manages assets for institutional investors and high-net-worth individuals. As of 2025, it employs approximately 12 professionals and focuses on event-driven investment strategies, seeking to deliver absolute returns through investments across public and private markets.

Investment Strategy

Newtyn Management employs a fundamental, event-driven investment strategy with a value-oriented approach. The firm seeks to identify opportunities where significant value can be realized through mergers, acquisitions, restructurings, or other catalysts. It typically invests in both public equities and, periodically, private transactions, with a strong focus on downside protection and risk-adjusted returns. The firm is known to engage proactively with portfolio companies and may seek to influence outcomes to unlock shareholder value.

Latest 13F Filing Activity

Newtyn Management, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 32 equity positions with a total 13F market value of $660M. The fund increased holdings in Compass Minerals Intl Inc., Indivior PLC, Site CTRS Corp. among other positions. Newtyn Management, LLC reduced exposure to Millrose PPTYS Inc., Iac Inc., Amn Healthcare SVCS Inc. among others.

Top Buys
C
CMPCOMPASS MINERALS INTL INC
+$25.7M
I
INDVINDIVIOR PLC
+$22.7M
S
SITCSITE CTRS CORP
+$12.4M
T
TBPHTHERAVANCE BIOPHARMA INC
+$12.1M
B
BVBRIGHTVIEW HLDGS INC
+$11.9M
Top Sells
M
MRPMILLROSE PPTYS INC
-$30.0M
I
IACIAC INC
-$28.1M
A
AMNAMN HEALTHCARE SVCS INC
-$23.4M
T
TSVT2SEVENTY BIO INC
-$12.5M
C
CLFDCLEARFIELD INC
-$8.9M

Top Holdings

C
CNNECANNAE HLDGS INC
+14.0%$92.3M
T
TBPHTHERAVANCE BIOPHARMA INC
+8.3%$54.6M
Q
QDELQUIDELORTHO CORP
+7.4%$49.2M
A
AIVAPARTMENT INVT & MGMT CO
+6.8%$44.9M
B
BVBRIGHTVIEW HLDGS INC
+6.3%$41.4M

Equity Positions (32)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
CANNAE HLDGS INC13.98%$92.3M4,425,000$18.74$20.85+$7.9M
THERAVANCE BIOPHARMA INC8.27%$54.6M4,950,000$8.92$11.03+$12.1M
QUIDELORTHO CORP7.45%$49.2M1,705,668$31.64$28.82+$6.7M
APARTMENT INVT & MGMT CO6.80%$44.9M5,190,472$8.15$8.65+$897.6K
BRIGHTVIEW HLDGS INC6.28%$41.4M2,487,572$13.08$16.65+$11.9M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+17.5%
RETAIL-EATING & DRINKING PLACES
+14.0%
REAL ESTATE INVESTMENT TRUSTS
+13.7%
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
+7.4%
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.
+7.2%

Investment Team (6)

NameRoleLocationLinkedIn
K
Karam Sethi
Investment ProfessionalNew York, NY , United States
D
Dan Fitzpatrick
AnalystNew York, NY , United States
E
Edwin G
AnalystNew York, NY , United States
F
Francois Gouws
Investment AnalystUnited States
Michael Dealy
Michael Dealy
Head Of TradingNew York, NY , United States
Noah Levy
Noah Levy
Managing PartnerNew York, NY , United States